Recommended Pages at fiercepharmamanufacturing.com
Congress probes whether small wholesalers are gouging drug prices - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Congress is investigating whether some small drug wholesalers are gaming the system by setting up their own pharmacies to get their hands on drugs in short supply, diverting them to their wholesale Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on March 23, 2012 at 2:27 pm By:
Cary Byrd - eDrugSearch.com Pharma and Health Advocate
Congress probes whether small wholesalers are gougin... http://t.co/LBWlSHey
Pfizer, Lilly and Sanofi help authorities break up counterfeiters - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “A gang believed to be importing fake drugs from Asia, including erectile dysfunction drug knockoffs, has been intercepted by authorities with the help of Pfizer ($PFE), Eli Lilly ($LLY) and Sanofi ( Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on March 21, 2012 at 4:20 pm By:
Healthcare In Focus Health Site
.@Pfizer @LillyPad and @SanofiUS help authorities break up drug counterfeiters http://t.co/FuCbxp6s
Abbott exec tapped for H&P manuf. ops - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Beleaguered OTC drugmaker H&P Industries said last week it had hired a former Abbott Laboratories ($ABT) exec to help the company dig out from its manufacturing hole. H&P operations were shut Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on September 7, 2011 at 6:44 pm By:
Former Abbott exec takes on COO role at H&P Industries--and the FDA consent decree that goes with it. http://t.co/eNsJ5eE #FDA #pharma
Vax maker CSL on road to GMP compliance - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “The common vaccine-making process of blending flu virus strains appears to have been a factor in the nearly 10% adverse reaction rate to CSL's Fluvax among children last year. Intermingling of the Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on September 7, 2011 at 6:33 pm By:
CSL's still working to clear up 2010 flu vax-reactions mystery. So far FDA 'satisfied with progress' http://t.co/kpwkE7g #FDA #vaccines
No penalties for stunning gray price hikes on cancer, anesthesia drugs - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “PBS Newshour health correspondent Betty Ann Bowser dove into the drug shortages pool recently, gaining access to Captain Valerie Jensen, assistant director for the FDA office that tracks shortages. Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on September 7, 2011 at 6:27 pm By:
FDA official: Gray-market suppliers hoard meds in anticipation of shortage, then jack up prices when it happens. http://t.co/t5dg8Jo
GSK sees resistance to wind turbine project - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “A green-minded GlaxoSmithKline ($GSK) is encountering some residential resistance to its goal of making its Montrose facility on Scotland's east coast carbon-neutral. A group called Ferryden opposes Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on September 7, 2011 at 6:20 pm By:
Glaxo wants to go carbon-neutral in Montrose, Scotland. But locals don't like its wind turbine plans. http://t.co/TZMLJMB $GSK #pharma
Pharma deal-making minimizes manufacturing - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Brand recognition outweighs manufacturing risk in Big Pharma thinking when it comes to growth by deal-making. In fact, "Brand acquisitions typically help buyers avoid any manufacturing risks." So Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on September 6, 2011 at 8:46 pm By:
Paul W. Thomas Health Communicator
RT @druginfoassn: #Pharma deal-making minimizes manufacturing http://t.co/hArCrwr
Time to put the innovation into manufacturing - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Recent drug discoveries and subsequent development failures have led some--investors and drugmakers among them--to question pharma's ability to innovate within the constraints of the current business Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 30, 2011 at 10:55 pm By:
Pharma innovation needs to extend to manufacturing and supply chain, too. http://t.co/KpAyfZU
Time to put the innovation into manufacturing - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Recent drug discoveries and subsequent development failures have led some--investors and drugmakers among them--to question pharma's ability to innovate within the constraints of the current business Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 30, 2011 at 4:28 pm By:
Paul W. Thomas Health Communicator
RT @fdazilla: what innovation is possible in #pharma manufacturing? http://ht.ly/6gFmi more than most think
U.K. competition heats up for new GSK plant - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “And they're off! Several U.K. local governments are vying for a new biomanufacturing plant and the hundreds of jobs that come with it. The proposed GlaxoSmithKline ($GSK) facility is described as one Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 25, 2011 at 8:59 pm By:
U.K. locales in the running for a new GSK biomanufacturing plant are scrambling for an advantage. http://t.co/L0IHZn8
Teva propofol plant closing followed jury award for hep C outbreak - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Generics-maker Teva ($TEVA) ceased propofol production three weeks after a jury awarded $500 million to school principal Henry Chanin in May 2010. Chanin contracted hepatitis C during a procedure in Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 25, 2011 at 8:55 pm By:
Testimony in Teva hep C liability trial: Co. locked up propofol plant 3 wks after $500m jury award in similar suit. http://t.co/rkVuGqr
China's drug regulator reins in CMOs - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “The China State Food and Drug Administration (SFDA) has beefed up its requirements on domestic contract manufacturers doing work for foreign drugmakers. Its aim is to prevent export counterfeiting, Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 25, 2011 at 8:48 pm By:
China's FDA beefed up rules for domestic CMOs working for foreign drugmakers. The aim: To combat counterfeiting. http://t.co/2jHxpzW
WHO sends Panacea to remediation - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “It's time to revise the revenue projections at Panacea Biotech. The World Health Organization, following a late June manufacturing plant inspection, has removed three of the drugmaker's combination Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 23, 2011 at 4:40 pm By:
WHO strikes some Panacea vaccines after inspectors uncovered quality problems at a Punjab, India, plant. http://t.co/8ekMJAb
Takeda parlays Baxter's vax methods into Japanese subsidies - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Takeda Pharmaceutical ($TKPHF) has scored again with its home government, this time winning a ¥23.9 billion ($311 million) subsidy to develop an advanced commercial production facility for new Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 23, 2011 at 4:25 pm By:
Takeda scored a $311 million subsidy for a new vaccine-production plant, thanks to Baxter's technology. http://t.co/eN9Wat2
Top drug shortages by treatment category - FiercePharma Manufacturing
fiercepharmamanufacturing.com — “Doctors, pharmacists and even the U.S. Congress use terms like "unprecedented," "crisis" and "significant risk" to describe current U.S. drug shortages. "We're getting to a tipping point, where we Read more...” View full resource at fiercepharmamanufacturing.com
Most Recently Shared on August 23, 2011 at 1:04 pm By:
RT @FiercePharma: Which drugs are scarcest? We've rounded up the most severe shortages by treatment category. http://t.co/ZM7UEZ9
